These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4150018)

  • 21. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
    Zaagsma J; Nauta WT
    J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug effects on blood pressure and heart rate in unanesthetized animals. (1). Effects of beta-blocking agents (author's transl)].
    Iizuka H; Nakagawa Y; Matsubara I; Imai S; Yanagita T
    Nihon Yakurigaku Zasshi; 1977 May; 73(4):401-9. PubMed ID: 20392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings: Relationship between the pharmacokinetic and pharmacodynamic properties of the beta-receptor antagonists alprenolol and metoprolol.
    Regardh CG; Ablad B; Borg KO; Johnsson G; Solvell L
    Acta Pharm Suec; 1974 Dec; 11(6):660. PubMed ID: 237405
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dose-response relationship of beta-adrenergic blocking agents].
    Seyberth H
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1663-5. PubMed ID: 4150008
    [No Abstract]   [Full Text] [Related]  

  • 25. Bis-arenoxypropanolamines as potential beta-adrenolytics: a reinvestigation.
    Da Re P; Valenti P; Fabbri G; Frigeni V; Reggiani A; Della Bella D
    Drugs Exp Clin Res; 1988; 14(11):687-92. PubMed ID: 2907738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
    Caputi AP; Marmo E; Saini RK
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
    [No Abstract]   [Full Text] [Related]  

  • 27. The pharmacological characterization of beta-sympathicolytic substances.
    Saameli K
    Indian Heart J; 1972 Jun; 24():Suppl 1:146-56. PubMed ID: 4147272
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
    Meyer RF; Stratton CD; Hastings SG; Corey RM
    J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: Antagonism by ICI 66082 of the effects of electrical stimulation on the right ansa subclavia of the dog.
    Harry JD; Knapp MF; Linden RJ
    Br J Pharmacol; 1974 Mar; 50(3):457P-458P. PubMed ID: 4153012
    [No Abstract]   [Full Text] [Related]  

  • 30. [Change of the reactibility of the myocardium following the termination of the beta-blocking effect of trimepranol and practolol].
    Svec P; Inczinger F; Béderová E; Zigová L
    Cesk Farm; 1977 May; 26(4):128-30. PubMed ID: 880637
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers.
    Graham BR; Littlejohns DW; Prichard BN; Scales B; Southorn P
    Br J Pharmacol; 1973 Sep; 49(1):154P-155P. PubMed ID: 4150762
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacology of 1-phenylaminoethylamino-3-(phenoxy)propanol derivatives with beta-adrenergic action].
    Femmer K; Heer S; Poppe H
    Pharmazie; 1983 Jun; 38(6):409-14. PubMed ID: 6136994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proceedings: The efferent pathway of the reflex increase in heart rate produced by stimulation of left arterial receptors.
    Kappagoda CT; Linden RJ; Scott EM; Snow HM
    J Physiol; 1974 Oct; 242(2):79P-80P. PubMed ID: 4156368
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical pharmacology of trimepranol (pharmacokinetic informations and effects on heart rate in healthy individuals)].
    Mayer O; Petrlík M; Vitous J; Cepelák V
    Vnitr Lek; 1976 Nov; 22(11):1102-9. PubMed ID: 12612
    [No Abstract]   [Full Text] [Related]  

  • 35. Prediction of the non-specific cardiodepressant effects of beta-adrenoceptor blocking agents in vitro and in vivo by means of the Hansch analysis.
    Hellenbrecht D; Grobecker H; Müller KF
    Eur J Pharmacol; 1974 Dec; 29(2):223-5. PubMed ID: 4155366
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
    Mouillé P; Cheymol G
    C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
    [No Abstract]   [Full Text] [Related]  

  • 38. [Beta-adrenolytic effect of a phenylbutylamino derivative].
    Greeff K; Greven G
    Arzneimittelforschung; 1969 Oct; 19(10):1763-4. PubMed ID: 5395386
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of the effects of some new derivatives of ethylenediamine on the cardiovascular system. Studies on general pharmacological properties.
    Filczewski M
    Acta Physiol Pol; 1974; 25(6):565-76. PubMed ID: 4456970
    [No Abstract]   [Full Text] [Related]  

  • 40. Central actions of some beta-adrenoceptor blocking agents.
    Shah UH; Jindal MN; Patel VK; Kelkar VV
    Arzneimittelforschung; 1974 Oct; 24(10):1581-4. PubMed ID: 4154760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.